China CAS:187164-19-8 Manufacturer

We believe that prolonged time period partnership is really a result of top of the range, benefit added provider, prosperous knowledge and personal contact for CAS:187164-19-8, we could solve our customer problems asap and do the profit for our customer. For those who need superior provider and excellent , pls choose us , thanks !
CAS:187164-19-8, We have constructed strong and long co-operation relationship with an enormous quantity of companies within this business overseas. Immediate and specialist after-sale service supplied by our consultant group has happy our buyers. Detailed Info and parameters from the merchandise will probably be sent to you for any thorough acknowledge. Free samples may be delivered and company check out to our corporation. n Portugal for negotiation is constantly welcome. Hope to get inquiries type you and construct a long-term co-operation partnership.

Hot Products

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate has USP、EP、 IP、JP and KP. DMF, GMP is available.

    CAS:71-58-9

  • Revefenacin

    Revefenacin

    Revefenacin has In-house specification. DMF approved.

    CAS:864750-70-9

  • 17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate is an endogenous progesteroid hormone similar to progesterone.

    CAS:302-23-8

  • Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3
    Specifications:0.2mg*3
    Indications:Abortion
  • Epiandrosterone

    Epiandrosterone

    Epiandrosterone is a steroid hormone with weak androgenic activity. It is a metabolite of testosterone and dihydrotestosterone (DHT).

    CAS:481-29-8

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept